19-50855382-C-T

Variant names:

• chr19-50855382-C-T
• rs266879
• ENST00000596185.5:n.*112C>T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2 BP4_Strong

The ENST00000596185.5(KLK3):​n.*112C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: not found (cov: 31)
  • Exomes 𝑓: 0.0 (0 hom.)
  • Failed GnomAD Quality Control
• Consequence: KLK3 ENST00000596185.5 non_coding_transcript_exon
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -3.29
• Publications: 4 publications found

Genes affected

KLK3 (HGNC:6364): (kallikrein related peptidase 3) Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. It encodes a single-chain glycoprotein, a protease which is synthesized in the epithelial cells of the prostate gland, and is present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. The serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms. [provided by RefSeq, Dec 2019]

ACMG classification

Our verdict: Likely_benign. The variant received -2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.89).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000596185.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	KLK3	NM_001648.2	MANE Select	c.46+381C>T		intron	N/A	NP_001639.1
	KLK3	NM_001030047.1		c.46+381C>T		intron	N/A	NP_001025218.1
	KLK3	NM_001030048.1		c.46+381C>T		intron	N/A	NP_001025219.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	KLK3	ENST00000596185.5	TSL:1	n.*112C>T		non_coding_transcript_exon	Exon 1 of 5	ENSP00000471648.1
	KLK3	ENST00000601349.5	TSL:1	n.468C>T		non_coding_transcript_exon	Exon 1 of 4
	KLK3	ENST00000596185.5	TSL:1	n.*112C>T		3_prime_UTR	Exon 1 of 5	ENSP00000471648.1

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0 AN: 80500 Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0 AN XY: 41948

African (AFR) AF: 0.00 AC: 0 AN: 2630

American (AMR) AF: 0.00 AC: 0 AN: 4442

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 2522

East Asian (EAS) AF: 0.00 AC: 0 AN: 4436

South Asian (SAS) AF: 0.00 AC: 0 AN: 8168

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 3686

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 372

European-Non Finnish (NFE) AF: 0.00 AC: 0 AN: 49528

Other (OTH) AF: 0.00 AC: 0 AN: 4716

GnomAD4 genome Cov.: 31

Alfa AF: 0.00 Hom.: 573

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.89
CADD	Benign	0.023
DANN	Benign	0.60
PhyloP100		-3.3
PromoterAI		0.012	Neutral

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs266879; hg19: chr19-51358638;